News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Vinay Prasad: We estimate how many people are eligible for CAR-T
Photo from Vinay Prasad/Twitter
Feb 5, 2024, 11:23

Vinay Prasad: We estimate how many people are eligible for CAR-T

Vinay Prasad, Professor in the Department of Epidemiology and Biostatistics at the University of California San Francisco, shared a post on X/Twitter:

“Just out in Blood Advances: We estimate how many people are eligible for CAR-T.
The answer: Best case scenario 3.9%, and <2% of cancer patients respond.”

Further details.
Source: Vinay Prasad/X

blood advances cancer CAR-T Hematology hemonc immunotherapy OncoDaily Oncology Vinay Prasad
Special Coverage
Blog
Jan 17, 2025, 18:14
Jemma Arakelyan: The Global Clinical Research Governance Conference
Blog
Jan 17, 2025, 18:02
2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents - SPCC
Blog
Jan 17, 2025, 17:53
Intermittent or Continuous FOLFIRI + Panitumumab RAS and BRAF Wild-Type Metastatic CRC
Positive
Jan 17, 2025, 17:53
Megan-Claire Chase: For anyone doubting their voice, keep telling your story
Blog
Jan 17, 2025, 17:51
Sabine D. Brookman-May: The Effect of Resistance and/or Aerobic Training on Quality of Life in prostate cancer
Blog
Jan 17, 2025, 17:45
AACR - Cellular Therapies in ALL
Blog
Jan 17, 2025, 17:28
Yale Cancer Center Diversity Enhancement Program in Oncology
Opinion
Jan 17, 2025, 17:21
Senthil Kumar: Systemic Treatment for Advanced/Metastatic Gastrointestinal and Pancreatic Neuroendocrine Tumors
Insight
Jan 17, 2025, 17:20
Advancing Lung Cancer Screening: Insights from Central and Eastern Europe
Insight
Jan 17, 2025, 17:15
Perspectives and Innovation in Pediatric Psycho-Oncology - AIEOP
Blog
Jan 17, 2025, 17:11
The countdown begins for the 17th BGICC - Sharing Progress in Cancer Care
Blog
Jan 17, 2025, 17:03
Hear Her will be an everlasting love of the Florez Lab